Innovations in next-generation sequencing (NGS) are helping the genomics community ask, and answer, increasingly complex scientific questions. Over the last 20 years, Illumina has sought to improve sequencing capabilities across the entire workflow, making platforms easier to use while driving down costs. Combined with the latest advances in optics and instrument design, the NextSeq 2000 increases data output and reduces the cost per run, all while maintaining the same high-quality data users have come to expect from the Illumina Systems. Attend this session to learn more about Illumina’s newest platform and see performance data for exome sequencing, single-cell profiling, and transcriptome sequencing.
Fiona Nohilly
Senior Product Marketing Manager
Illumina
Wendy Goldstein
Senior Applications Scientist
Illumina
Your email address is never shared with third parties.